NOVAZOI THERANOSTICS
Biotech · Private
Biomarker-driven therapeutics targeting HSET and nucleoporin pathways in triple-negative breast cancer
- Grants
- $415K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 4 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A novel racial disparity marker for risk prediction in triple negative breast cancer patients | $207,544 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel racial disparity marker for risk prediction in triple negative breast cancer patients | $207,544 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2156 | Mindset Pharma Inc. | — | $694K |
| 2157 | Bitterroot Bio | — | — |
| 2158 | ASL Analytical, Inc. | — | $2.4M |
| 2159 | NOVAZOI THERANOSTICS | — | — |
| 2160 | PSYENCE BIOMEDICAL LTD. | — | $2.0M |
| 2161 | MITORAINBOW THERAPEUTICS, INC. | — | — |
| 2162 | Avanti Biosciences Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method For Determining The Risk Profile Of Neoplastic Tissuegranted
- Ethanolamine-based Lipid Biosynthetic Compounds, Method Of Making And Use Thereofgranted
- Compositions And Methods For Prognosis And Treatment Of Neoplasmapplication
- Compositions And Methods For Prognosis And Treatment Of Neoplasmgranted
- Method For Determining The Risk Profile Of Neoplastic Tissuegranted
- Compositions And Methods For Prognosis And Treatment Of Cancerapplication
- Compositions And Methods For Prognosis And Treatment Of Neoplasmapplication
- Method For Determining The Risk Profile Of Neoplastic Tissueapplication
- Compositions And Methods For Prognosis And Treatment Of Cancerapplication
- Phosphatidylethanolamine Lipid Biosynthetic Compounds, Method Of Making And Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.